Full name
"ESKULAP"G.CZARNECKI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
52.21 - Service activities incidental to land transportation
64.92 - Other credit granting
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,3 | -0,3 | -0,5 | -70,4 |
Gross profit (loss) | -0,4 | -0,3 | -0,5 | -72,7 |
EBITDA | -0,2 | -0,2 | -0,5 | -87,3 |
Short time liabilities | 7,1 | 8 | 8,4 | 4,8 |
Other operating costs | 0 | 0,1 | 0,1 | 66,3 |
Equity capital | 4,9 | 4,6 | 4,1 | -11,7 |
Operating profit (EBIT) | -0,3 | -0,3 | -0,5 | -69,9 |
Assets | 12 | 12,7 | 12,5 | -1,2 |
Net profit (loss) | -0,4 | -0,3 | -0,5 | -72,7 |
Cash | 0,1 | 0 | 0 | -68,5 |
Net income from sale | 3,5 | 4,3 | 4,6 | 8,8 |
Liabilities and provisions for liabilities | 7,1 | 8 | 8,4 | 4,8 |
Working assets | 2,8 | 3,5 | 3,4 | -2,4 |
Other income costs | 0 | 0 | 0 | 53,9 |
Depreciation | 0,1 | 0,1 | 0,1 | 0,5 |
% | % | % | p.p. | |
Profitability of capital | -7,5 | -6,8 | -13,3 | -6,5 |
Equity capital to total assets | 41 | 36,4 | 32,5 | -3,9 |
Gross profit margin | -10,6 | -7,3 | -11,7 | -4,4 |
EBITDA Margin | -5,7 | -5,9 | -10,1 | -4,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 739 | 690 | 665 | -25 |
Current financial liquidity indicator | 0.39700254797935486 | 0.4370603859424591 | 0.4067986011505127 | 0 |
Net dept to EBITDA | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane